Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the Oct. 4-8 SupplySide West Conference in Las Vegas. Now in its 20th year, SupplySide West remains a one-stop resource to accelerate manufacturers’ ability to find ingredients to aid in successful launches of finished products.HempMeds® representatives will be exhibiting a …
HempMeds® representatives will be exhibiting a wide range of retail-ready cannabis products at booth J137 at the Mandalay Bay, including its CBD hemp oil raw ingredient and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Also on display will be its groundbreaking Real Scientific Hemp Oil™ (RSHO™), which helped reshape international cannabis laws in Paraguay and Brazil.
“SupplySide West provides us with a great opportunity to educate some of the more than 14,000 global buyers and manufacturers that attend the Expo about our CBD hemp oil products, which have become highly sought after by consumers across the globe, and the plethora of benefits they can provide to patients around the world,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “We are proud to be the world’s most trusted supplier of CBD products and look forward to providing a cannabis product as a nutritional supplement to the manufacturers of products attending the Expo.”
Expo hours are Thursday, Oct. 6, from 10 a.m. — 5:30 p.m. and Friday, Oct. 7, from 10 a.m. — 5 p.m.
Hemp oil products from HempMeds® are readily available to ship to all 50 U.S. states, districts and territories, plus more than 40 countries around the world. For more information on HempMeds® and their all-natural hemp oil products, visit: www.hempmeds.com. For more information on SupplySide West 2016, visit http://west.supplysideshow.com.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500